ICC ICC Labs Inc

ICC Responds to Media Reports

ICC Responds to Media Reports

VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC) is aware of a recent Spanish language media report speculating as to a potential transaction involving the acquisition of the Company. The policy of the Company is not to comment on rumors or speculation in the marketplace or any potential transaction unless, and until, a binding legal agreement to effect that transaction has been signed. 

However, in response to a request from the Investment Industry Regulatory Organization of Canada, the Company confirms that it engages from time to time in discussions with other industry players regarding various alternatives.  There can be no assurance that the Company will enter into any transaction or take any other corporate action as a result of any such discussions.  ICC does not intend to make any further comment on this matter except as may be required by applicable securities laws.

ABOUT ICC LABS INC.

ICC Labs is a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay as well as a fully licensed producer of medicinal cannabis in Colombia. The Company has active operations in Uruguay, and is focused on becoming the worldwide leading producer of cannabinoid extracts, giving support and promoting responsible use for medicinal purposes, backed by scientific research and innovation, while following strict compliance with standards for quality and safety.

For more information, please visit .

Contact:

ICC Labs Inc.

Alejandro Antalich, Chief Executive Officer

t: 598-2900-0000 ext. 404

e:

Neither the TSX Venture Exchange (the “TSX-V”) nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s future production and sales, results of operations, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements.

EN
23/08/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICC Labs Inc

 PRESS RELEASE

ICC Labs Obtains Final Order For Arrangement With Aurora Cannabis

ICC Labs Obtains Final Order For Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that the Supreme Court of British Columbia has issued a final order (the Final Order) approving the plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an arrangement agreement between ICC and Aurora dated September 8, 2018 (the Arrangement Agreement), Aurora will acquire all of the issued and outsta...

 PRESS RELEASE

ICC Labs Announces Shareholder Approval of Arrangement With Aurora Can...

ICC Labs Announces Shareholder Approval of Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC) (TSX-V: ICC) is pleased to announce that, at the special meeting of shareholders of ICC (ICC Shareholders) held today (the Meeting), ICC Shareholders overwhelmingly voted in favour of a special resolution (the Arrangement Resolution) to approve the previously announced plan of arrangement (the Arrangement) between ICC and Aurora Cannabis Inc. (Aurora) (TSX: ACB, NYSE: ACB). Subject to the terms and conditions of an ar...

 PRESS RELEASE

Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition o...

Aurora Cannabis Receives Lenders’ Consent for Proposed Acquisition of ICC Milestone towards Completing Transaction to Establish Leadership in South American Market EDMONTON, Alberta and VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (Aurora) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and ICC Labs Inc. (ICC) (TSX-V: ICC) are pleased to announce that Aurora has received, from its consortium of lenders led by Bank of Montreal (collectively, the Lenders), consent and approval as required under its credit agreement with the Lenders to the previou...

 PRESS RELEASE

ICC Labs Provides Information About Circular

ICC Labs Provides Information About Circular VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (ICC or the Company) (TSX-V: ICC) confirms that the management information circular dated October 3, 2018 (the Circular), form of proxy and other materials with respect to the Company’s proposed plan of arrangement (the Arrangement) with Aurora Cannabis Inc. (Aurora) have been mailed to holders (the ICC Shareholders) of common shares of ICC (the ICC Shares) of record as of September 26, 2018 in accordance with an interim order of the Supreme Court of British Columbia. ...

 PRESS RELEASE

ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis

ICC Labs Obtains Interim Order for Arrangement With Aurora Cannabis VANCOUVER, British Columbia, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (the Company or ICC Labs) (TSX-V: ICC) is pleased to announce that it has obtained an interim order of the Supreme Court of British Columbia authorizing, among other things, the holding of the Company’s special meeting of holders (the ICC Shareholders) of common shares (ICC Shares). At the meeting, the ICC Shareholders will be asked to consider and vote on a special resolution (the Arrangement Resolution) approving a statutory plan of arrangement...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch